Expert Consensus on the Use of Teprotumumab for the Management of Thyroid Eye Disease Using a Modified-Delphi Approach.
Douglas RS, Kossler AL, Abrams J, Briceño CA, Gay D, Harrison A, Lee M, Nguyen J, Joseph SS, Schlachter D, Tan J, Lynch J, Oliver L, Perry R, Ugradar S.
Douglas RS, et al. Among authors: joseph ss.
J Neuroophthalmol. 2022 Sep 1;42(3):334-339. doi: 10.1097/WNO.0000000000001560. Epub 2022 Mar 24.
J Neuroophthalmol. 2022.
PMID: 35421877
Free PMC article.